Nestle Health Science
Nestle Health Science is a Switzerland-based pharmaceutical firm that develops and supplies products such as medicinal drugs and supplements for the healthcare sector.
Business Model:
Revenue: $5.3B
Employees: 5,001-10,000
Rankings
Industries / Tags:
Detailed Nestle Health Science Information
Geographic Data
Address: Avenue Nestle 55
City: Vevey
State: geneva
Zip: 1800
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
1,010,015Website Global Rank
33,923Website Monthly Traffic
Twitter Followers
Description
Nestle Health Science is a Switzerland-based pharmaceutical firm that develops and supplies products such as medicinal drugs and supplements for the healthcare sector.
Contact Phone:
+18185487050
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2018 | Aimmune Therapeutics | Post-IPO Equity | 98M |
| 11/2016 | Aimmune Therapeutics | Post-IPO Equity | 145M |
| 2/2020 | Aimmune Therapeutics | Equity | 200M |
| 6/2020 | ENTEROME | Series E | 51.9M |
| 1/2018 | ENTEROME | Debt Financing | - |
| 4/2016 | ENTEROME | Series C | 16.4M |
| 11/2018 | Axcella | Series E | 0 |
| 7/2021 | ProciseDx | Convertible Note | 0 |
| 12/2022 | Ruipeng Pet Healthcare | Private Equity Round | - |
| 1/2015 | Seres Therapeutics | Series D | 65M |
| 7/2011 | Vital Foods | Venture Round | - |
| 2/2016 | Axcella | Series D | 42.5M |
| 4/2019 | Amazentis | Venture Round | - |
| 1/2017 | ENTEROME | Series D | 33.4M |
| 7/2021 | ProciseDx | Convertible Note | 0 |
| 6/2020 | ENTEROME | Series E | 0 |
| 2/2020 | Aimmune Therapeutics | Post-IPO Equity | 0 |
| 4/2019 | Amazentis | Venture Round | - |
| 11/2018 | Aimmune Therapeutics | Post-IPO Equity | 0 |
| 11/2018 | Axcella | Series E | 0 |
| 1/2018 | ENTEROME | Debt Financing | - |
| 1/2017 | ENTEROME | Series D | 0 |
| 11/2016 | Aimmune Therapeutics | Post-IPO Equity | 0 |
| 4/2016 | ENTEROME | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2022 | Puravida | |
| 2/2022 | Orgain | |
| 8/2020 | Aimmune Therapeutics | |
| 8/2020 | IM HealthScience | |
| 6/2020 | Vital Proteins | |
| 8/2019 | Persona | |
| 9/2016 | Phagenesis | |
| 5/2011 | Prometheus Biosciences |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
